Feature | ASTRO | August 30, 2019 | By Greg Freiherr

How ASTRO 2019 Will Be Different From Past ASTRO Meetings

First of three-meeting transformation

Beginning with the 2019 meeting, the American Society for Radiation Oncology (ASTRO) will begin transforming its annual meeting in several key ways

Expect changes at ASTRO 2019 and at ASTRO annual meetings to come over the next two years. Photo courtesy of ASTRO

Greg Freiherr

Greg Freiherr

Beginning with the 2019 meeting, the American Society for Radiation Oncology (ASTRO) will begin transforming its annual meeting in several key ways — some obvious, others subtle.

The meeting will emphasize debate, discussion and collaboration, as ASTRO continues to showcase research, offer panel discussions and display new technologies for cancer care. The goal behind this newfound emphasis is to increase the impact and value of the meeting, according to the ASTRO website. Toward this goal, ASTRO 2019 will debut an interactive format for the Presidential Symposium, “Curing Metastatic Disease with Radiotherapy — Myth or Reality?” and a closing session that highlights some of the big takeaway points of the meeting. Included will be discussions about trends, advances and what might be coming. Critical to this transformation is the society’s redesign of the Presidential Symposium, a redesign meant to build the ASTRO community through an interactive learning experience, according to Laura Thevenot, CEO of ASTRO.

This redesign sets the stage for attendees to learn “in a new and different way,” said Thevenot. “There will be more discussion between attendees and speakers.” This will be facilitated partly by breakout sessions.

“We're transforming traditional learning with this meeting, and the Presidential Symposium sets the stage for this change,” Thevenot said.

Curated digital poster stations with interrelated topics are expected to generate discussion and collaboration. These stations, however, won’t be markedly different from those of the annual meeting last year, when ASTRO introduced the digital poster format. This digital poster format is continuing, according to an ASTRO spokesperson. Similarly, Industry Expert Theaters in the Exhibit Hall will undergo no major changes. (These are sponsored presentations by ASTRO’s industry partners that complement the science and educational programming at the meeting.)

The Exhibit Hall/Innovation Hub will be enhanced in the coming years but not at this year’s meeting. “In the future, we will be expanding these areas to be a space where big ideas and innovative concepts are catalyzed,” said the ASTRO spokesperson.

Those attending the meeting will find what the society describes as a “reimagined curriculum.” At the end of their talks, speakers will provide key takeaways to be drawn from their presentations or research. Talks will be shorter than at previous ASTRO annual meetings with sessions running between 60 and 75 minutes versus the 90-minute sessions of past meetings.

In addition to being shorter, sessions will include more integrated audience polling, a focus on experiential learning, mixed seating in session rooms — with a mix of roundtables, pod seating, classroom and theater-style seating to foster collaboration and engagement — and new formats such as breakouts and debates. The goal behind presentations will be to highlight top science including new reports and long-term updates of clinical trials and other high-impact studies in prostate, breast, lung and other major cancers.

Among the important new features will be “journey maps” that highlight key sessions for various types of attendees. Also included will be enhancements to the mobile app; these enhancements will create a true “second-screen experience for attendees,” Thevenot said. And there will be special wellness events such as sunrise yoga sessions; a special luncheon; healthy food options; and more free time to relax and network.

Future ASTRO annual meetings will see further expansion of interactive learning formats; a focus on physician wellness and well-being; an emphasis on the intersection of entrepreneurship and research; a more global focus; and a reimagined meeting experience, including new concepts of how we use the space outside of session rooms Thevenot said, “We also anticipate seeing more multi-disciplinary research that looks at radiation in combination with immunotherapies and other emerging treatments.”

The ASTRO chief executive wants to encourage attendees, as well as “those who can't join us in Chicago,” to follow meeting developments using #ASTRO19.

Greg Freiherr is a contributing editor to Imaging Technology News. Over the past three decades, he has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

Related content:

Top Radiation Oncology Research and Clinical Trials at ASTRO 2019 

PTW to Feature New Dosimetry Technology at ASTRO 2019 

Moffitt Researchers Develop Model to Personalize Breast Cancer Radiation Treatment 

VIDEO: Artificial Intelligence Automatic Contouring and Segmentation For Radiotherapy 

MRIdian System Limits Early Toxicity for Prostate Cancer Without Implanted Markers 

 

 

Related Content

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital.

Prof. Dr. Samer Ezziddin from Saarland University/Saarland University Hospital. Photo courtesy of Thorsten Mohr/Saarland University

News | Prostate Cancer | November 28, 2019
November 28, 2019 — Reports of new cancer treatments
FerrAlert technology automatically detects and logs ferromagnetic events and exclusively provides a photographic stream which is date and time stamped
News | Magnetic Resonance Imaging (MRI) | November 22, 2019
November 22, 2019 — Kopp Development Inc. acquired Mednovus, Inc.
One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published today in the Journal of Oncology Practice
News | Clinical Trials | November 21, 2019
November 21, 2019 — One in three adults treated for cancer may experience side effects from treatment they wish they
•	Sports Imaging is a unique specialty that allows radiologists to collaborate across the care continuum from detection to treatment

Image courtesy of Carestream Health

Feature | Radiology Business | November 18, 2019 | By Neelesh S. Prakash, M.D.
International Radiology Day (IDoR
Image by Pexels from Pixabay RSNA 2019

Image by Pexels from Pixabay 

News | RSNA | November 15, 2019
November 15, 2019 – The 105th Scientific Assembly and Annual Meeting of the...
Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model)

Image by whitfieldink from Pixabay

News | Radiation Oncology | November 13, 2019
November 13, 2019 — Members of Congress from both sides of the aisle issued a series of oversight letters to the...
The ALS produces various wavelengths of bright light that can be used to explore the microscopic chemistry, structure, and other properties of samples

Two researchers from Cairo University in Egypt brought 32 bone samples and two soil samples to study using X-ray and infrared light-based techniques at Berkeley Lab's Advanced Light Source (ALS). The ALS produces various wavelengths of bright light that can be used to explore the microscopic chemistry, structure, and other properties of samples. Image courtesy of Marilyn Sargent/Berkeley Lab

News | Radiology Imaging | November 13, 2019
November 13, 2019 — Experiments at the Department of Energy's Lawrence Berkeley National Laboratory (...